ConductScience.org, home

Trial · NCT03094416

Outcomes14

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYThyroid Stimulating Hormone (TSH)baseline and 12 weeksintention to treat (ITT), 4 subjects not considered in the analysis because of drop-out or LT4 dose changemIU/LMEAN
SECONDARYFree Thyroxine (FT4)baseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changepmol/LMEAN
SECONDARYTotal Thyroxine (TT4)baseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changenmol/LMEAN
SECONDARYFree Triiodothyronine (FT3)baseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changepmol/LMEAN
SECONDARYTotal Triiodothyronine (TT3)baseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changenmol/LMEAN
OTHER_PRE_SPECIFIEDCreatine Phosphokinase (CPK)baseline and 12 weeksITT, 6 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedU/LMEAN
OTHER_PRE_SPECIFIEDSex Hormone Binding Globulin (SHBG)baseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changenmol/LMEAN
OTHER_PRE_SPECIFIEDFerritinbaseline and 12 weeksITT, 4 subjects not considered in the analysis because of drop-out or LT4 dose changemcg/LMEAN
OTHER_PRE_SPECIFIEDAngiotensin Converting Enzyme (ACE)baseline and 12 weeksITT, 9 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedU/LMEAN
OTHER_PRE_SPECIFIEDTriglyceridesbaseline and 12 weeksITT, 7 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedmmol/LMEAN
OTHER_PRE_SPECIFIEDCholesterol, Totalbaseline and 12 weeksITT, 7 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedmmol/LMEAN
OTHER_PRE_SPECIFIEDLow Density Lipoprotein (LDL)-Cholesterolbaseline and 12 weeksITT, 8 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedmmol/LMEAN
OTHER_PRE_SPECIFIEDHigh Density Lipoprotein (HDL)-Cholesterolbaseline and 12 weeksITT, 7 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedmmol/LMEAN
OTHER_PRE_SPECIFIEDVery Low Density Lipoprotein (VLDL)-Cholesterolbaseline and 12 weeksITT, 8 subjects not considered in the analysis because of drop-out, LT4 dose change or laboratory test not performedmmol/LMEAN

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03094416/outcomes